BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4645070)

  • 1. [Distribution and chemotherapeutic activity of daunomycin and adriamycin in spontaneous mammary carcinoma of mice].
    Lenaz L; Di Fronzo G
    Tumori; 1972; 58(4):213-8. PubMed ID: 4645070
    [No Abstract]   [Full Text] [Related]  

  • 2. Antineoplastic activity and pharmacokinetics of adriamycin and daunomycin in tumor bearing mice.
    Martini A; Donelli NG; Mantovani A; Pacciarini MA; Fogar-Ottaviano EF; Morasca L; Garattini S; Spreafico FS
    Oncology; 1977; 34(4):173-8. PubMed ID: 917449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time dependent cytotoxicity of adriamycin and daunomycin in primary cultures of normal and neoplastic mammary glands.
    Morasca L; Fogar-Ottaviano EG; Garattini S
    Eur J Cancer (1965); 1976 Feb; 12(2):107-11. PubMed ID: 944129
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological and therapeutic efficacy of rubidazone in mice. Comparison with daunomycin and adriamycin.
    Ohnuma T; Elias F; Holland JF; Henderson E
    Eur J Cancer (1965); 1979 Mar; 15(3):363-71. PubMed ID: 446517
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic, toxicologic, and chemotherapeutic properties of detorubicin in mice: a comparative study with daunorubicin and adriamycin.
    Deprez-de Campeneere D; Baurain R; Trouet A
    Cancer Treat Rep; 1979 May; 63(5):861-7. PubMed ID: 455327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to mice.
    Pacciarini MA; Barbieri B; Colombo T; Broggini M; Garattini S; Donelli MG
    Cancer Treat Rep; 1978 May; 62(5):791-800. PubMed ID: 657163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intercalation with DNA is a prerequisite for daunomycin, adriamycin and its congeners in inhibiting DNAase I.
    Facchinetti T; Mantovani A; Cantoni L; Cantoni R; Salmona M
    Chem Biol Interact; 1978 Jan; 20(1):97-102. PubMed ID: 630649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of adriamycin and daunomycin on spleen cell populations in normal and tumor allografted mice.
    Mantovani A; Tagliabue A; Vecchi A; Spreafico F
    Eur J Cancer (1965); 1976 May; 12(5):381-7. PubMed ID: 1085252
    [No Abstract]   [Full Text] [Related]  

  • 9. A differential interaction of daunomycin, adriamycin, and N-trifluoroacetyladriamycin 14-valerate with mouse peritoneal macrophages.
    Facchinetti T; Raz A; Goldman R
    Cancer Res; 1978 Nov; 38(11 Pt 1):3944-9. PubMed ID: 212183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic toxicology of mitomycin C, actinomycins, daunomycin and adriamycin.
    Vig BK
    Mutat Res; 1977; 39(2):189-238. PubMed ID: 68434
    [No Abstract]   [Full Text] [Related]  

  • 11. Mammary tumors induced in rats by adriamycin and daunomycin.
    Solcia E; Ballerini L; Bellini O; Sala L; Bertazzoli C
    Cancer Res; 1978 May; 38(5):1444-6. PubMed ID: 639071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin.
    Goodman J; Hochstein P
    Biochem Biophys Res Commun; 1977 Jul; 77(2):797-803. PubMed ID: 20093
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of adriamycin and daunomycin on antitumoral immune effector mechanisms in an allogeneic system.
    Mantovani A; Vecchi A; Tagliabue A; Spreafico F
    Eur J Cancer (1965); 1976 May; 12(5):371-9. PubMed ID: 954795
    [No Abstract]   [Full Text] [Related]  

  • 14. The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities.
    Hurwitz E; Levy R; Maron R; Wilchek M; Arnon R; Sela M
    Cancer Res; 1975 May; 35(5):1175-81. PubMed ID: 164279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction with mitochondria of the anthracycline cytostatics adriamycin and daunomycin.
    Porumb H; Petrescu I
    Prog Biophys Mol Biol; 1986; 48(2):103-25. PubMed ID: 3029807
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and biological evaluation of some 14-O-acyl derivatives of adriamycin.
    Arcamone F; Franceschi G; Minghetti A; Penco S; Redaelli S
    J Med Chem; 1974 Mar; 17(3):335-7. PubMed ID: 4811230
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of cytosine arabinoside, daunomycin, mithramycin, azacytidine, adriamycin, and camptothecin on mammalian cell cycle traverse.
    Tobey RA
    Cancer Res; 1972 Dec; 32(12):2720-5. PubMed ID: 4118765
    [No Abstract]   [Full Text] [Related]  

  • 18. The differential effects produced by daunomycin and adriamycin on RNA, polynucleotides, single stranded, supercoiled DNA, and nucleosomes.
    Pearlman LF; Simpkins H
    Biochem Biophys Res Commun; 1985 Sep; 131(2):1033-40. PubMed ID: 2413842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammary tumor induction in male and female Sprague-Dawley rats by adriamycin and daunomycin.
    Bucclarelli E
    J Natl Cancer Inst; 1981 Jan; 66(1):81-4. PubMed ID: 6935469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ca2+-transport inhibition by the antitumor agents adriamycin and daunomycin.
    Anghileri LJ
    Arzneimittelforschung; 1977; 27(6):1177-80. PubMed ID: 578437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.